DBV Technologies (DBVT) EBITDA Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -249,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -249,028.00 |
| Dec 31, 2025 | -173,674.00 |
| Sep 30, 2025 | 126,098.00 |
| Jun 30, 2025 | 55,468.00 |
| Mar 31, 2025 | -112,481.00 |
| Dec 31, 2024 | -519,655.00 |
| Sep 30, 2024 | -161,580.00 |
| Jun 30, 2024 | -186,319.00 |
| Mar 31, 2024 | -138,889.00 |
| Dec 31, 2023 | -150,669.00 |
| Sep 30, 2023 | 70,436.00 |
| Jun 30, 2023 | 116,927.00 |
| Mar 31, 2023 | -4,265.00 |
| Dec 31, 2022 | 200,489.00 |
| Sep 30, 2022 | 52,091.00 |
| Jun 30, 2022 | -36,949.00 |
| Mar 31, 2022 | 57,042.00 |
| Dec 31, 2021 | -297,856.00 |
| Sep 30, 2021 | -166,731.00 |
| Jun 30, 2021 | -70,423.00 |
| Mar 31, 2021 | -31,029.00 |
| Sep 30, 2020 | 76,077.00 |
| Sep 30, 2019 | 28,728.00 |
| Dec 31, 2015 | -1,643.00 |
| Jun 30, 2015 | -210,552.00 |